INC424
Showing 26 - 50 of 519
Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis Trial in Canada,
Terminated
- Primary Myelofibrosis
- +2 more
- Ruxolitinib Pre- Hematopoietic cell transplantation (HCT)
-
Atlanta, Georgia
- +7 more
Feb 28, 2019
Alzheimer's Disease Trial in Worldwide (Aducanumab (BIIB037), Placebo)
Terminated
- Alzheimer's Disease
- Aducanumab (BIIB037)
- Placebo
-
Birmingham, Alabama
- +179 more
Aug 9, 2021
Alzheimer's Disease Trial in Worldwide (Placebo, Gantenerumab)
Geographic Atrophy Trial in Worldwide (APL-2, Sham Procedure)
Active, not recruiting
- Geographic Atrophy
- APL-2
- Sham Procedure
-
Phoenix, Arizona
- +140 more
Jun 20, 2022
Corticosteroid Refractory Acute GVHD Trial in Worldwide (Ruxolitinib, Best Available Therapy (BAT))
Completed
- Corticosteroid Refractory Acute Graft vs Host Disease
- Ruxolitinib
- Best Available Therapy (BAT)
-
Westmead, New South Wales, Australia
- +102 more
Sep 1, 2021
Parkinson Disease Trial (CVN424 150 mg, Placebo)
Not yet recruiting
- Parkinson Disease
- CVN424 150 mg
- Placebo
- (no location specified)
Aug 25, 2023
Bacterial Conjunctivitis Trial in Worldwide (SHP640, PVP-I 0.6%, Placebo)
Giant Cell Arteritis (GCA) Trial in Worldwide (Upadacitinib, Corticosteroid (CS), Placebo)
Recruiting
- Giant Cell Arteritis (GCA)
- Upadacitinib
- +2 more
-
Huntsville, Alabama
- +173 more
Aug 23, 2022
Patients With Leptomeningeal Metastases ((LM) Using CNSide
Recruiting
- Leptomeningeal Metastasis
- +4 more
- CNSide
-
Los Angeles, CaliforniaValkyrie Clinical Trials
Sep 7, 2022
Lung Adenocarcinoma Trial in Los Angeles (drug, procedure, other)
Recruiting
- Lung Adenocarcinoma
-
Los Angeles, CaliforniaYesenia Calzada
Jan 27, 2023
Open-Angle Glaucoma, Ocular Hypertension Trial in Worldwide (Bimatoprost (SR))
Recruiting
- Open-Angle Glaucoma
- Ocular Hypertension
- Bimatoprost (SR)
-
Sun City, Arizona
- +112 more
Aug 16, 2022
Polycythemia Vera Trial in Worldwide (ruxolitinib tablets, Best Available Therapy (BAT))
Completed
- Polycythemia Vera
- ruxolitinib tablets
- Best Available Therapy (BAT)
-
Birmingham, Alabama
- +101 more
Feb 8, 2019
Cerebral Stroke, Traumatic Brain Injury, Spinal Cord Injuries Trial in Los Angeles (HandyMotion Treatment Program)
Not yet recruiting
- Cerebral Stroke
- +2 more
- HandyMotion Treatment Program
-
Los Angeles, CaliforniaCalifornia Rehabilitation Institute
Oct 9, 2023
Uveal Melanoma, Metastatic Trial in Tampa (4.7 microCi 225Ac-MTI-201, 9.5 microCi of 225Ac-MTI-201, 19 microCi of 225Ac-MTI-201)
Recruiting
- Uveal Melanoma
- Metastatic
- 4.7 microCi 225Ac-MTI-201
- +11 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Aug 9, 2022
Polycystic Ovary Syndrome Trial in Santa Monica (Elix Daily Harmony, Elix Cycle Balance)
Recruiting
- Polycystic Ovary Syndrome
- Elix Daily Harmony
- Elix Cycle Balance
-
Santa Monica, CaliforniaCitruslabs
May 15, 2023
Early and Sustained Pain Control in Radiographic Axial
Recruiting
- Radiographic Axial Spondylarthritis (r-axSpA)
-
La Plata, Buenos Aires, Argentina
- +162 more
Jan 12, 2023
Triple Negative Breast Cancer Trial in United States (Trilaciclib, Sacituzumab Govitecan-hziy)
Recruiting
- Triple Negative Breast Cancer
- Trilaciclib
- Sacituzumab Govitecan-hziy
-
Chandler, Arizona
- +21 more
Oct 25, 2022
Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Worldwide (Quadrivalent VLP Vaccine, Quadrivalent
Completed
- Virus Diseases
- +3 more
- Quadrivalent VLP Vaccine
- Quadrivalent Comparator Vaccine
-
Mobile, Alabama
- +103 more
Oct 29, 2020
Rheumatoid Arthritis (RA) Trial in Worldwide (ABBV-154, Placebo)
Active, not recruiting
- Rheumatoid Arthritis (RA)
- ABBV-154
- Placebo
-
Phoenix, Arizona
- +222 more
Jun 7, 2022
Metastatic Breast Cancer Trial in United States (Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane
Recruiting
- Metastatic Breast Cancer
- Enobosarm & Abemaciclib Combo
- non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant
-
Chandler, Arizona
- +29 more
Feb 1, 2023